We shifted last year with the legislature. We actually are using some of that money for our inhaler initiative in the public schools through Calex. And We made the determination with biocon that their existing facility in Virginia was more than adequate to provide enough manufactured product for the state of California. So that gave us the flexibility to investigate that alternative. An option. And working with the legislature last year, we redirected a lot of those funds. (26:44–26:55)
CLAIM
Asserts that Biocon's Virginia facility can supply enough product for California.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.